Stay updated on Carfilzomib Combo for Myeloma Clinical Trial

Sign up to get notified when there's something new on the Carfilzomib Combo for Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carfilzomib Combo for Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The 'Multiple Myeloma' keyword and the 'MedlinePlus Genetics' related topic were removed from the page's related topics. This reduces disease-specific tagging and external topic linking for the study page.
    Difference
    0.2%
    Check dated 2025-10-26T20:33:24.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    3%
    Check dated 2025-10-05T09:06:01.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Replace 'Plasma cell myeloma' with 'Multiple myeloma' and update version to v3.1.0 while removing v3.0.2.
    Difference
    0.2%
    Check dated 2025-09-28T03:06:03.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing the previous v3.0.1 tag; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-13T16:43:20.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The web page has been updated to include information on Multiple myeloma under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.4%
    Check dated 2025-09-06T14:07:39.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to plasma cell myeloma and various chemical compounds. Notably, daratumumab has been added while previous mentions of multiple myeloma and certain medications have been removed.
    Difference
    5%
    Check dated 2025-08-30T11:05:43.000Z thumbnail image

Stay in the know with updates to Carfilzomib Combo for Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carfilzomib Combo for Myeloma Clinical Trial page.